Denmark· DK-28107198124
Haloperidol "Orifarm"
A haloperidol product containing haloperidoldecanoat, registered in Denmark by Orifarm A/S. The same ATC class is registered in 18 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Haloperidol is registered in 18 of 19 countries.
Countries holding a registration under ATC N05AD01 (haloperidol), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 10 of them publish a price we can compare per daily dose
Haloperidol · ATC N05AD01
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of haloperidol costs, country by country.
Normalised to the WHO defined daily dose (8 mg), the median price runs from $0.095 in Spain to $1.54 in Switzerland — a ×16 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Haloperidol · price per daily dose (8 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.54
- FR France$0.22
- ES Spain$0.095
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- HALOPERIDOLDECANOAT
- Manufacturer
- Orifarm A/S
- Country
- Denmark (DK)
- ATC code
- N05AD01
- ATC class
- Haloperidol
- Defined daily dose
- 8 mg, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28107198124
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
469 interactions on record for haloperidol.
Graded by severity as the source publishes them — 135 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Haloperidol · interactions on record
469 records
- 135 severe
- 167 moderate
- 6 minor
- 88 info
Most severe, free to view
- PapaverineA03AD01severe
- MetoclopramideA03FA01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
73 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under N05AD01
Haloperidol, as other registers publish it.
- ItalyALOPERIDOLO PENSATOWA PHARMACEUTICAL S.P.A.
- PolandDecaldolZakłady Farmaceutyczne POLPHARMA S.A.
- United KingdomDozic 5mg/5ml oral solutionRosemont Pharmaceuticals Ltd
- SwitzerlandHaldol
- GermanyHaldolEssential Pharma Limited
- IcelandHaldolEssential Pharma Limited
- SwitzerlandHaldol
- IcelandHaldolEssential Pharma Limited
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c729bc6d-0602-4f98-9b9c-4b004adbcdf5 GET /v1/drugs/c729bc6d-0602-4f98-9b9c-4b004adbcdf5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "injektionsvæske, opløsning",
"source": "dkma",
"strength": "100 mg/ml",
"auth_role": "DKMA",
"dk_drugid": "28107198124",
"substance": "HALOPERIDOLDECANOAT",
"auth_procedure": "Par-Imp",
"in_medicinpriser": true,
"registration_date_serial": "45618"
}See everything about haloperidol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.